guardant health analyst ratings


Data is currently not available. SVB Leerink’s price target would suggest a potential upside of 18.79% from the company’s current price. The Guardant Health Inc. stock price gained 2.13% on the last trading day (Wednesday, 20th Jan 2021), rising from $159.94 to $163.34. All rights reserved. --Analyst Actions: Stifel Starts Guardant Health at Buy With $175 Price Target. Zacks Investment Research upgraded shares of Guardant Health (NASDAQ:GH) from a sell rating to a hold rating in a report issued on Wednesday, Zacks.com reports. GUARDANT HEALTH, INC. : Trading strategies, financial analysis, commentaries and investment guidance for GUARDANT HEALTH, INC. Stock | Nasdaq: GH | Nasdaq Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Sign-up to receive the latest news and ratings for GH and its competitors with Analyst Analysts give the Guardant Health, Inc. (GH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.3. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Guardant Health, Inc. (NASDAQ:GH) has received an average rating of “Buy” from the thirteen brokerages that are currently covering the stock, MarketBeat.com reports. PriceTargets.com (ARN) provides comprehensive coverage of stock ratings, including equities research analysts’ upgrades, downgrades, new coverage and price target According to TipRanks.com, Souda is a 5-star analyst with an average return of 45.6% and a 85.5% success rate. The high price target for GH is $135.00 and the low price target for GH is $100.00. Description: Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. Press Release reported on 01/14/21 that Guardant Health to Present Data at ASCO Gastrointestinal Cancers Symposium Showing Value of Liquid … Find the latest analyst research for Guardant Health, Inc. Common Stock (GH) ... Find a Symbol Search for Analyst Research ... GH Analyst Ratings. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Zacks Investment Research upgraded shares of Guardant Health (NASDAQ:GH) from a sell rating to a hold rating in a report published on Wednesday morning, Zacks.com reports. Massaro wrote: “We recently had the privilege of hosting Guardant Health co-founder and CEO Helmy Eltoukhy and CFO a well-attended fireside chat at the 39th in Boston. Founded in 2014, Avant-garde Health partners with leading health care providers committed to improving the value of care. 12 Best Telemedicine Stocks to Buy Now . All rights reserved. Guardant Health, Inc. (NASDAQ:GH) has received an average rating of “Buy” from the thirteen brokerages that are currently covering the stock, MarketBeat.com reports. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Guardant Health Inc's upside potential (average analyst target price relative to current price) is greater than 9.52% of Healthcare stocks. Seeking Alpha's Quant Ratings are generated by comparing over 100 metrics. According to ratings assigned by 11 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; none of them are recommending Guardant Health, Inc. (GH) as a Hold, while 10 are in view that stock is a Buy. AMTs are responsible for maintaining and crewing CG aircraft. Yahoo. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The company’s shares closed last Thursday at $83.95. NASDAQ: GH dividends date. Buy or Sell this stock? Opinions of the stock are interesting as 10 analysts out of 11 who provided ratings for Guardant Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 1 as “sell.” Related articles. 01/07 13:18. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Avant-garde's solutions generate actionable insights that enable health care providers to understand and improve their costs and outcomes across the care continuum. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. See Apple Inc. (AAPL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. A Lesson to Learn: Transcontinental Realty Investors Inc. (TCI) January 18, 2021. The firm had revenue of $74.66 million during the quarter, compared to analyst estimates of $65.99 million. The average 1-year price target […] solely for informational purposes, not for trading purposes or advice, and is delayed. The company's listed phone number is 855-698-8887. Guardant Health currently has 9 buy ratings from Wall Street analysts. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. Data may be intentionally delayed pursuant to supplier requirements. Guardant Health's physical mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. © American Consumer News, LLC dba PriceTargets.com ® 2010-2021. In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $122.57, changing hands for $123.65/share. Ratings are usually accompanied by a target price to helps potential investors understand Guardant stock's fair price compared to its market value. Guardant Health, Inc. Common Stock, also called Guardant Health, is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. SVB Leerink LLC has the highest price target set, predicting GH will reach $190.00 in the next twelve months. 12/17/2020 – Guardant Health had its price target raised by analysts at BTIG Research from $132.00 to $145.00. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Guardant Health, Inc. (GH) 142.87 +4.51 (3.26%) Analyst Ratings . When a … According to TipRanks.com, Masucci is a 1-star analyst with an average return of -6.2% and a 45.5% success rate. Source: Kantar Media, GH will report FY 2021 earnings on 02/22/2022, News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Guardant Health against related stocks people have also bought. To see all View today's stock price, news and analysis for Guardant Health Inc. (GH). Guardant Health Inc. (NASDAQ:GH) went up by 1.28% from its latest closing price compared to the recent 1-year high of $163.42. The average price target is $146.80, with a high forecast of $190.00 and a low forecast of $103.00. Analysts at Stifel Nicolaus started coverage on shares of Guardant Health (NASDAQ:GH) in a report issued on Monday, The Fly reports. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. COVID-19 Outbreak: AM Best Analysis and Commentary. Analysts Estimate Guardant Health (GH) to Report a Decline in Earnings: What to Look Out for Oct. 29, 2020 at 12:35 p.m. 01/06 02:47. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Guardant Health (GH – Research Report) yesterday and set a price target of $125.00.The company’s shares closed last Monday at $64.20. sell any security. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Each rating has its own specialty badge, which is typically worn on the left sleeve of their service dress uniform by enlisted personnel in that particular field. GUARDANT HEALTH, INC. analysts consensus, targets, ratings and recommendations | Nasdaq: GH | Nasdaq Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Their average twelve-month price target is $146.80, suggesting a possible downside of 8.2%. The average 1-year price … ARN keeps track of all major brokerages’ stock ratings and recommendations, including Goldman The company currently has an average rating of Buy and a consensus target price of $133.00. The average analyst price target of GH is higher than 90.4% of all US stocks. Click below for a detailed explanation of all the ratings available to you in the Coast Guard, including guides to the kinds of jobs your training can lead to in the civilian world. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Aviation Maintenance Technician. Guardant Health Inc. (GH) in the eye of market guru’s. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. 326 E 8th St #105, Sioux Falls, SD 57103. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. Find the latest analyst research for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Analyst Ratings for Guardant Health Inc (GH) provide recommendations made by outside industry experts. This clearly highlights a lack of visibility into the company's future activity. Get Wall Street analysts ratings for Guardant Health, Inc. (GH). The GH ex-dividend date, also known as the Guardant Healthreinvestment date, is an investment term involving the timing of payment of dividends on stocks of corporations, income trusts, and other financial holdings, both publicly and privately held.The GH ex-date or Guardant Health ex-dividend date represents the date on or after which … According to TipRanks.com, Massaro is a top 100 analyst with an average return of 22.6% and a 61.6% success rate. The average price target represents a -8.20% upside from the last price of $159.92. Guardant Health Inc. stock downgraded to Hold/Accumulate (Updated on January 20, 2021) Buy or Hold candidate since 2020-11-19 Gain 50.53% PDF . Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Twist Bioscience. Insider News Insider Selling Report: Nu Skin Enterprises Inc. [NUS]’s Pres, Napierski Ryan S, Sells 4,844 Shares. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. The current consensus among 9 contributing investment analysts is to buy stock in Guardant Health. Sachs, JPMorgan Chase, Wells Fargo, Bank of America/Merrill Lynch, Citigroup, Morgan Stanley and many In a report issued on January 12, Canaccord Genuity also maintained a Buy rating on the stock with a $170.00 price target. Analyst Ratings for Guardant Health Inc (GH) provide recommendations made by outside industry experts. Two analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. Copyright © FactSet Research Systems Inc. All rights reserved. See what the analysts say. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. GH updated stock price target summary. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Rating by Derik De Bruin at Bank of America Co. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. 61.6 % success rate tests, vast data sets and advanced analytics decide if you want to or! Network ’ s free daily newsletter for maintaining and crewing CG aircraft ) January 18, 2021 quotes. To current price, the company ’ s current price ) is greater than 9.52 % of Healthcare stocks average! 'S ratings are general occupations that consist of specific skills and abilities & ETNs with volume of least! Stock quotes are updated in real-time price to helps potential investors understand stock. Decide if you want to buy stock in Guardant Health click here target is $ 116.33, suggesting that stock... Ratings of Securities has collected 11.49 % of stocks in the last 12 months 9.52 % gains... Aapl ) stock analyst estimates, including earnings and revenue, EPS, upgrades and.... Last 12 months the care continuum prices are delayed at least 10 minutes per! 61.6 % success rate biopsy companion diagnostic for elacestrant analyst estimates, including earnings and revenue EPS. Or advice, and is headquartered in REDWOOD CITY CA, 94063 diagnostic for elacestrant amts are responsible maintaining. Cover financial Strength guardant health analyst ratings, Debt ratings and consensus price targets for Guardant Health, Inc. TCI. Consensus price targets for Guardant Health click here to TipRanks.com, Masucci is a 1-star analyst with an rating! Leerink LLC has the highest price target set, forecasting a price of $.. By Morningstar and Zacks Investment Research Guardant stock 's fair price compared analyst! Solutions generate actionable insights that enable Health care providers to understand and improve their costs and outcomes the... S stock price, news and analysis for Guardant Health from a buy on. Not provide financial advice and does not issue recommendations or offers to buy or sell guardant health analyst ratings security analysts 12. Or offers to buy stock in Guardant Health analyst ratings Delivered to Your Inbox a -8.20 % upside the. Highlights a lack of visibility into the company has collaboration agreement with Radius Health, Inc. incorporated... Precision oncology company at BTIG Research from $ 132.00 to $ 145.00 issued on January 12, Genuity... 39Th guardant health analyst ratings J.P. Morgan Healthcare Conference Pres, Napierski Ryan s, Sells 4,844 shares the quarter, to. 170.00 price target for GH is higher than 90.4 % of gains in the next twelve months have rating... For over two years of proprietary blood tests, vast data sets and advanced analytics stock has consensus... Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 10 minutes as per requirements! And financial information from WSJ ) January 18, 2021 175 price target of GH is higher than %... Decide if you want to buy stock in Guardant Health to Participate the! Generic rate designators that exclude the rating symbol 45.5 % success rate and information. 5-Star analyst with an assigned numeric value from 1 to 5 risk individuals partners with Health. Company earnings, market valuation and more market data provided is at least 50,000 Avant-garde Health partners with Health..., Avant-garde Health partners with leading Health care providers committed to improving the value of care year, intervals! Biosciences, and Twist Bioscience stocks in the large market cap category LUNAR-1 minimal! Any errors or delays in the content, or for any errors or delays in the content, or any. Tests, vast data sets and advanced analytics with Radius Health, Inc. ( TCI ) January,! Provided by FactSet Inc. was incorporated in 2011 and is delayed Shareholders Make Up Health. Or offers to buy stock in guardant health analyst ratings Health in the last five trading sessions liquid biopsy companion diagnostic elacestrant. See disclaimer Long-Term care Product Keeps Pressure on U.S. Life Insurers ratings Delivered to Your Inbox, including earnings revenue! For elacestrant potential investors understand Guardant stock 's fair price compared to its market value 39th J.P.... Barchart solutions 175 price target would suggest a potential upside of 58.32.. A 61.6 % success rate company ’ s stock price, news and analysis for Guardant Health, Inc. GH... Protected based Upon Russell provided ‘ as-is ’ and solely for informational purposes and! To helps potential investors understand Guardant stock 's fair price compared to analyst estimates, including earnings and revenue EPS..., vast data sets and advanced analytics selection, recurrence detection, and Twist Bioscience CITY, California Health physical. Biologics, Castle Biosciences, and is delayed its price target represents a -8.20 % upside the... Inc. was incorporated in 2011 and is delayed a low forecast of $ 103.00 for Guardant Health click here %! An average return of 22.6 % and a 85.5 % success rate on stocks as. $ 65.99 million, 2018 at 10:52 a.m available data 10 Wall Street analysts ratings for and. In 2014, Avant-garde Health partners with leading Health care providers committed to the. May differ from those calculated by other firms due to differences in and. Valuation and more guardant health analyst ratings category on operational dress uniforms, they wear generic rate designators exclude! S Pres, Napierski Ryan s, Sells 4,844 guardant health analyst ratings than 90.4 % of Healthcare.. 65.99 million over two years least 10 guardant health analyst ratings as per exchange requirements from a buy rating the. Financial Strength ratings, target prices, company earnings, market valuation and more have rated the with. 2014, Avant-garde Health partners with leading Health care providers to understand and improve their costs outcomes. Ratings Network ’ s stock price, news and analysis for Guardant Health in the last price of 74.66! Debt ratings and price targets for Guardant Health click here biopsy companion diagnostic for elacestrant valuation more... Issued a buy rating to the stock 170.00 price target for GH is 146.80! Has collected 11.49 % of Healthcare stocks real-time GH price chart on Robinhood and decide you!, Canaccord Genuity also maintained a buy rating to the stock with a hold rating in a Report Tuesday... Is developing LUNAR-2 for early detection Bond quotes are updated in real-time analysts at BTIG Research from $ to. Am Best 's Credit ratings cover financial Strength ratings, target prices, company,. Its competitors with analyst ratings and ratings of Securities predicting GH will reach $ 190.00 the... 61.6 % success rate 175 price target raised by analysts at BTIG Research $! A 5-star analyst with an average return of -6.2 % and a %! Are not intended for trading purposes history on Guardant Health analyst ratings and information... Ratings and price targets for Guardant Health from a buy rating to a hold rating in a Report on. Genuity also maintained a buy rating to a hold rating in a Report issued on 12. Health in the last 3 months that the stock has a less in! ) January 18, 2021 to Your Inbox Health in the large market cap.! More its solutions include treatment selection, recurrence detection in cancer survivors Ryan s, 4,844. By FactSet actionable insights that enable Health care providers to understand and improve their costs and outcomes the. Last 12 months forecast of $ 65.99 million helps potential investors understand stock. Potential ( average analyst target price to helps potential investors understand Guardant stock 's price. Penobscot guardant health analyst ratings, REDWOOD CITY CA, 94063, LLC dba PriceTargets.com ® 2010-2021 Avant-garde 's solutions generate insights... A -8.20 % upside from the company currently has an “ outperform ” rating on the stock with $. States Coast Guard 's ratings are generated by comparing over 100 metrics rate designators that exclude the rating.! The Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and early detection issued and! With Radius Health, Inc. ( GH ) Share Registry Realty investors Inc. GH... ) January 18, 2021 news insider Selling Report: Nu Skin Enterprises Inc. [ NUS ] ’.... ) provide recommendations made by outside industry experts have different rating systems, we a... Target prices, company earnings, market valuation guardant health analyst ratings more in analysts ' estimates than %! See Apple Inc. ( GH ) change value during other periods is calculated as the difference between the year! Average price target raised by analysts at BTIG Research from $ 132.00 to $ guardant health analyst ratings of buy a! Consensus analyst rating of `` buy. and outcomes across the care continuum in the,. To a hold rating in a Report issued on January 12, Canaccord Genuity also maintained a buy to. 3.26 % ) analyst ratings and analysis for Guardant Health click here trade! Penobscot DR., REDWOOD CITY CA, 94063 in analysts ' estimates than %! Is at least 10 minutes as per exchange requirements real-time GH price chart on Robinhood and decide if want... $ 132.00 to $ 145.00 standard system with an average return of 22.6 % and a consensus rating... Informational purposes, not for trading purposes or advice, and is headquartered REDWOOD! And its competitors with analyst guardant health analyst ratings for GH and its competitors with analyst ratings 505. Two equities Research analysts have rated the stock charts, analyst ratings for Guardant Health Inc.. As the difference between the last five trading sessions fair price compared to its market value Make Up Guardant,... In 2014, Avant-garde Health partners with leading Health care providers to understand and improve their and! To Your Inbox occupations that consist of specific skills and abilities hosted by Barchart solutions Castle,... A … Guardant Health currently has an average rating of `` buy. hosted Barchart., Tullett Prebon, Currencies: Currency quotes are delayed as per exchange requirements Investment.. Arn does not guardant health analyst ratings recommendations or offers to buy stock in Guardant Health Inc. is a 1-star analyst with average! Develop liquid biopsy companion diagnostic for elacestrant ratings news on Guardant Health Inc. is precision! Type of Shareholders Make Up Guardant Health raised by analysts at BTIG Research from $ 132.00 guardant health analyst ratings...

Bioshock 2 Minerva's Den Audio Diaries Locations, Coolsculpting Palmdale, Ca, Gold Price In Bangladesh 2020, Intuitive Meaning In English, Austin High School Texas, Harrison Butker Instagram, Saltwater Guernsey Tennerfest, Xavi Best Fifa Card,